| EX1231 IMMUNOHISTOCHEMISTRY: PD-L1 CLONE 22C3 (DAKO) |
| Specimen: |
Submit Tissue in 10% formal-saline OR formalin-fixed paraffin-embedded Tissue Block. Ship at room temperature. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| NA |
NA |
NA |
|
| Method: |
IHC |
| Comment: |
Samples received on holidays will be reported in the next schedule / next working day. |
| Report: |
Contact us to know the TAT. |
| Usage: |
PD-L1 (Programmed Death Ligand 1) is expressed on tumor cells and binds with PD-1 which is expressed on immune cells. This interaction hampers the immune response against tumor cells. Drugs have been developed to block this interaction & boost the immune response. PD-L1 expression is used to guide immunotherapy decisions. Clone 22C3 is indicated as a companion diagnostic aid in identifying patients for treatment with Pembrolizumab in the following tumors: Non-small-cell Lung carcinoma (NSCLC), Gastric or Gastroesophageal junction adenocarcinoma, Cervical carcinoma, Urothelial carcinoma, Head and neck squamous cell carcinoma (HNSCC) & Esophageal squamous cell carcinoma (ESCC). |
| Doctor Specialty: |
Oncologist |
| Disease: |
Cancer |
| Components: |
|
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Histopathology |
| Pre Test Information: |
Provide a copy of the Histopathology report, Site of biopsy, and Clinical history. |
Reviews
There are no reviews yet.